US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invivyd, Inc.

1.37

-0.1400-9.27%

Post-market: 1.450.0788+5.75%19:59 EDT

Volume:2.58M

Turnover:3.65M

Market Cap:386.34M

PE:-4.49

High:1.56

Open:1.48

Low:1.36

Close:1.51

52wk High:3.07

52wk Low:0.4600

Shares:282.00M

Float Shares:204.00M

Volume Ratio:0.92

T/O Rate:1.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3048

EPS(LYR):-0.3048

ROE:-33.96%

ROA:-17.09%

PB:1.60

PE(LYR):-4.49

Loading ...

Overview Company News Filings

Institutional investors in Invivyd, Inc. (NASDAQ:IVVD) see US$113m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.

BUZZ-Invivyd rises after team-up with Olympic skier Lindsey Vonn

Invivyd announces partnership with ski champion Lindsey Vonn

Invivyd Partners with Lindsey Vonn to Promote Antibody Education

Invivyd Announces Partnership With World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention

THOMSON REUTERS

Invivyd to Launch Mid-Stage Trial for Investigational Antibody on Long COVID

MT Newswires Live

Invivyd and Spear Study Group Announce Plan for Phase 2 Study of Vyd2311 for Treatment of Long Covid and Covid Vaccine-Injured Individuals to Commence Mid-2026

THOMSON REUTERS

Invivyd, SPEAR Study Group plan to initiate Phase 2 trial of VYD2311

Invivyd Reports Preliminary Q4 Revenue and Launches Phase 3 DECLARATION Trial

Invivyd Inc - Prelim Q4 2025 Pemgarda Revenue of $17.2 Mln

THOMSON REUTERS

Press Release: Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights

Invivyd Price Target Maintained With a $10.00/Share by BTIG

BUZZ-U.S. STOCKS ON THE MOVE-Invivyd, US natgas companies, New Era Energy

Invivyd Shares Gain 3.8% After Co Starts Late-Stage Trial for Covid Prevention Antibody

THOMSON REUTERS

Invivyd Shares up 2% Premarket After Co Starts Late-Stage Trial for Covid Prevention Antibody

THOMSON REUTERS

BUZZ-Invivyd rises as drugmaker starts late-stage trial for COVID prevention antibody

Invivyd Inc - FDA Grants Fast Track Designation for Invivyd's Vyd2311

THOMSON REUTERS

FDA Grants Fast Track Designation to Invivyd's COVID Prevention Antibody VYD2311

Invivyd Launches Phase 3 Trial of VYD2311 Antibody for COVID Prevention

Invivyd Inc - Top-Line Data Expected Mid-2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IVVD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVVD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":1.37,"timestamp":1774641600000,"preClose":1.51,"halted":0,"volume":2577663,"hourTrading":{"tag":"盘后","latestPrice":1.4488,"preClose":1.37,"latestTime":"19:59 EDT","volume":18923,"amount":25973.47,"timestamp":1774655946473,"change":0.0788,"changeRate":0.057518,"amplitude":0.080073},"delay":0,"changeRate":-0.0927152317880794,"floatShares":204000000,"shares":282000000,"eps":-0.304791,"marketStatus":"Market Closed","change":-0.14,"latestTime":"03-27 16:00:00 EDT","open":1.475,"high":1.5562,"low":1.36,"amount":3649158.5863887,"amplitude":0.129934,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.304791,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":1.51,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.51,"latestTime":"09:26 EDT","volume":14652,"amount":21764.1936204,"timestamp":1774618009335,"change":-0.01,"changeRate":-0.006623,"amplitude":0.02649},"postHourTrading":{"tag":"盘后","latestPrice":1.4488,"preClose":1.37,"latestTime":"19:59 EDT","volume":18923,"amount":25973.47,"timestamp":1774655946473,"change":0.0788,"changeRate":0.057518,"amplitude":0.080073},"volumeRatio":0.916908,"impliedVol":1.2421,"impliedVolPercentile":0.506},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","floatShares":204000000,"roa":"-17.09%","roe":"-33.96%","lyrEps":-0.304791,"volumeRatio":0.916908,"shares":282000000,"dividePrice":0,"high":1.5562,"amplitude":0.129934,"preClose":1.51,"low":1.36,"week52Low":0.46,"pbRate":"1.60","psRate":"7.23","week52High":3.0699,"institutionHeld":0,"latestPrice":1.37,"eps":-0.304791,"divideRate":0,"volume":2577663,"delay":0,"ttmEps":-0.304791,"open":1.475,"prevYearClose":2.47,"prevWeekClose":1.38,"prevMonthClose":1.69,"prevQuarterClose":2.47,"fiveDayClose":1.38,"twentyDayClose":1.69,"sixtyDayClose":2.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVVD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"IVVD","fiscalQuarterEnding":"2025/12","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":0},{"date":"2026-01-08","symbol":"IVVD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1767862800000,"name":null,"time":"Pre-Market","dateTimestamp":1767848400000,"actualEps":null},{"market":"US","date":"2025-11-06","symbol":"IVVD","fiscalQuarterEnding":"2025/09","expectedEps":-0.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-08-14","symbol":"IVVD","fiscalQuarterEnding":"2025/06","expectedEps":-0.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"IVVD","fiscalQuarterEnding":"2025/03","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVVD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVVD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1766462400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IVVD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IVVD","date":"2026-03-27","current":-4.494883,"percent":0.135727,"low":-54.35026,"twenty":-3.492431,"median":-1.128781,"eighty":-0.615752,"high":-0.170743,"avg":-4.195116,"sd":8.347502,"marketCap":426718040},"quantilePoints":[{"date":"2021-08-06","current":-20.235974,"twenty":-12.209882,"median":-0.170743,"eighty":-0.170743,"marketCap":2265932260},{"date":"2021-08-13","current":-25.837695,"twenty":-26.477338,"median":-22.901153,"eighty":-8.196835,"marketCap":2893187455},{"date":"2021-08-20","current":-26.787468,"twenty":-26.857247,"median":-25.973377,"eighty":-21.081078,"marketCap":2999538682},{"date":"2021-08-27","current":-29.442955,"twenty":-27.834156,"median":-26.254432,"eighty":-22.790669,"marketCap":3296888030},{"date":"2021-09-03","current":-41.082517,"twenty":-30.582682,"median":-26.903767,"eighty":-24.407221,"marketCap":4600233167},{"date":"2021-09-10","current":-52.237501,"twenty":-34.346884,"median":-27.107289,"eighty":-25.864831,"marketCap":5849317474},{"date":"2021-09-17","current":-49.87276,"twenty":-41.574848,"median":-28.333272,"eighty":-25.990822,"marketCap":5584524623},{"date":"2021-09-24","current":-43.437403,"twenty":-45.837563,"median":-31.3425,"eighty":-26.070293,"marketCap":4863922575},{"date":"2021-10-01","current":-27.799143,"twenty":-45.332177,"median":-32.752622,"eighty":-26.167208,"marketCap":3112821446},{"date":"2021-10-08","current":-34.098162,"twenty":-44.772716,"median":-31.663999,"eighty":-26.477338,"marketCap":3818156971},{"date":"2021-10-15","current":-32.220379,"twenty":-44.391197,"median":-31.942189,"eighty":-26.810728,"marketCap":3607891333},{"date":"2021-10-22","current":-33.531847,"twenty":-43.143316,"median":-32.796234,"eighty":-26.944471,"marketCap":3754743525},{"date":"2021-10-29","current":-29.050998,"twenty":-41.908316,"median":-32.394248,"eighty":-27.107289,"marketCap":3252998538},{"date":"2021-11-05","current":-19.910465,"twenty":-41.574848,"median":-31.842835,"eighty":-27.107289,"marketCap":2229483266},{"date":"2021-11-12","current":-19.016283,"twenty":-41.160049,"median":-31.463508,"eighty":-26.167208,"marketCap":2129356772},{"date":"2021-11-19","current":-10.754495,"twenty":-40.958465,"median":-30.898976,"eighty":-23.930397,"marketCap":2232820816},{"date":"2021-11-26","current":-13.460534,"twenty":-40.462257,"median":-30.670462,"eighty":-19.910465,"marketCap":2794641699},{"date":"2021-12-03","current":-24.557973,"twenty":-40.277958,"median":-30.278016,"eighty":-20.235974,"marketCap":5098663577},{"date":"2021-12-10","current":-17.806272,"twenty":-39.274486,"median":-29.442955,"eighty":-19.910465,"marketCap":3696892661},{"date":"2021-12-17","current":-6.15155,"twenty":-36.830387,"median":-28.396375,"eighty":-19.016283,"marketCap":1277169056},{"date":"2021-12-23","current":-4.640455,"twenty":-35.773265,"median":-28.318734,"eighty":-17.731253,"marketCap":963439375},{"date":"2021-12-31","current":-3.890266,"twenty":-34.889434,"median":-27.107289,"eighty":-10.888458,"marketCap":807687051},{"date":"2022-01-07","current":-3.177586,"twenty":-34.726181,"median":-26.845617,"eighty":-10.250797,"marketCap":659722343},{"date":"2022-01-14","current":-3.054341,"twenty":-34.716142,"median":-26.109059,"eighty":-6.024018,"marketCap":634134462},{"date":"2022-01-21","current":-3.370492,"twenty":-34.344559,"median":-25.973377,"eighty":-4.803353,"marketCap":699772941},{"date":"2022-01-28","current":-3.633058,"twenty":-33.758373,"median":-25.150086,"eighty":-4.146402,"marketCap":754286254},{"date":"2022-02-04","current":-4.41004,"twenty":-33.472235,"median":-24.833935,"eighty":-4.117466,"marketCap":915601161},{"date":"2022-02-11","current":-3.750945,"twenty":-33.414609,"median":-22.901153,"eighty":-4.037089,"marketCap":778761620},{"date":"2022-02-18","current":-3.440152,"twenty":-33.038815,"median":-20.249744,"eighty":-3.881692,"marketCap":714235657},{"date":"2022-02-25","current":-3.499096,"twenty":-32.761344,"median":-19.910465,"eighty":-3.803458,"marketCap":726473339},{"date":"2022-03-04","current":-2.695322,"twenty":-32.644704,"median":-19.383891,"eighty":-3.620198,"marketCap":559595849},{"date":"2022-03-11","current":-2.706039,"twenty":-32.425048,"median":-19.016283,"eighty":-3.495881,"marketCap":561820883},{"date":"2022-03-18","current":-2.663171,"twenty":-32.232302,"median":-18.082234,"eighty":-3.447654,"marketCap":552920750},{"date":"2022-03-25","current":-2.121963,"twenty":-32.069361,"median":-13.460534,"eighty":-3.399428,"marketCap":440556573},{"date":"2022-04-01","current":-2.185863,"twenty":-31.771301,"median":-10.864345,"eighty":-3.292258,"marketCap":495731781},{"date":"2022-04-08","current":-1.866688,"twenty":-31.632206,"median":-10.454419,"eighty":-3.196877,"marketCap":423346167},{"date":"2022-04-14","current":-1.736117,"twenty":-31.536113,"median":-10.036457,"eighty":-2.990039,"marketCap":393733871},{"date":"2022-04-22","current":-1.426614,"twenty":-31.313407,"median":-6.874947,"eighty":-2.80142,"marketCap":323541760},{"date":"2022-04-29","current":-1.38309,"twenty":-31.137425,"median":-5.513889,"eighty":-2.691035,"marketCap":313670994},{"date":"2022-05-06","current":-1.392762,"twenty":-30.873144,"median":-5.106644,"eighty":-2.665314,"marketCap":315864498},{"date":"2022-05-13","current":-1.033486,"twenty":-30.749945,"median":-4.774417,"eighty":-2.440927,"marketCap":298425270},{"date":"2022-05-20","current":-1.120876,"twenty":-30.64463,"median":-4.321625,"eighty":-2.212136,"marketCap":323659760},{"date":"2022-05-27","current":-1.132275,"twenty":-30.523419,"median":-4.206417,"eighty":-2.074048,"marketCap":326951215},{"date":"2022-06-03","current":-1.200668,"twenty":-30.451885,"median":-4.15819,"eighty":-1.963408,"marketCap":346699946},{"date":"2022-06-10","current":-1.124676,"twenty":-30.104147,"median":-3.970643,"eighty":-1.784476,"marketCap":324756912},{"date":"2022-06-17","current":-1.033486,"twenty":-30.05447,"median":-3.890266,"eighty":-1.562021,"marketCap":298425270},{"date":"2022-06-24","current":-1.27695,"twenty":-29.565258,"median":-3.847398,"eighty":-1.481744,"marketCap":368726981},{"date":"2022-07-01","current":-1.330156,"twenty":-29.129389,"median":-3.775058,"eighty":-1.43822,"marketCap":384090605},{"date":"2022-07-08","current":-1.569584,"twenty":-28.687364,"median":-3.66253,"eighty":-1.432587,"marketCap":453226914},{"date":"2022-07-15","current":-1.527779,"twenty":-28.386662,"median":-3.584832,"eighty":-1.439301,"marketCap":441155495},{"date":"2022-07-22","current":-1.580986,"twenty":-28.330364,"median":-3.496417,"eighty":-1.441122,"marketCap":456519119},{"date":"2022-07-29","current":-1.337757,"twenty":-28.318734,"median":-3.466945,"eighty":-1.439301,"marketCap":386285408},{"date":"2022-08-05","current":-1.520179,"twenty":-28.006979,"median":-3.442832,"eighty":-1.418008,"marketCap":438960692},{"date":"2022-08-12","current":-1.516378,"twenty":-27.384031,"median":-3.402643,"eighty":-1.425167,"marketCap":437863290},{"date":"2022-08-19","current":-1.549068,"twenty":-27.107289,"median":-3.34102,"eighty":-1.426035,"marketCap":457088205},{"date":"2022-08-26","current":-1.69291,"twenty":-26.985176,"median":-3.279398,"eighty":-1.431485,"marketCap":499532109},{"date":"2022-09-02","current":-1.762987,"twenty":-26.833988,"median":-3.247247,"eighty":-1.435834,"marketCap":520209909},{"date":"2022-09-09","current":-1.696599,"twenty":-26.632403,"median":-3.150793,"eighty":-1.43839,"marketCap":500620415},{"date":"2022-09-16","current":-1.416291,"twenty":-26.283507,"median":-2.973964,"eighty":-1.43839,"marketCap":417909216},{"date":"2022-09-23","current":-1.095413,"twenty":-26.089676,"median":-2.842681,"eighty":-1.425167,"marketCap":323226659},{"date":"2022-09-30","current":-1.166035,"twenty":-26.025711,"median":-2.786416,"eighty":-1.403926,"marketCap":344065403},{"date":"2022-10-07","current":-1.188387,"twenty":-25.919104,"median":-2.692642,"eighty":-1.367291,"marketCap":350660906},{"date":"2022-10-14","current":-1.221915,"twenty":-25.585157,"median":-2.679246,"eighty":-1.335295,"marketCap":360554160},{"date":"2022-10-21","current":-1.370929,"twenty":-25.161339,"median":-2.598869,"eighty":-1.327097,"marketCap":404524180},{"date":"2022-10-28","current":-1.464063,"twenty":-25.020946,"median":-2.452181,"eighty":-1.331555,"marketCap":432005442},{"date":"2022-11-04","current":-1.318774,"twenty":-24.880554,"median":-2.304152,"eighty":-1.330032,"marketCap":389134673},{"date":"2022-11-11","current":-1.402279,"twenty":-24.72355,"median":-2.205207,"eighty":-1.330032,"marketCap":392336643},{"date":"2022-11-18","current":-1.071185,"twenty":-24.116213,"median":-2.120061,"eighty":-1.321288,"marketCap":299701602},{"date":"2022-11-25","current":-0.833577,"twenty":-23.232604,"median":-2.052303,"eighty":-1.304144,"marketCap":233222338},{"date":"2022-12-02","current":-0.903691,"twenty":-22.029676,"median":-1.963408,"eighty":-1.287526,"marketCap":252839170},{"date":"2022-12-09","current":-0.771253,"twenty":-20.652703,"median":-1.869106,"eighty":-1.273678,"marketCap":215785153},{"date":"2022-12-16","current":-0.631026,"twenty":-20.24699,"median":-1.781428,"eighty":-1.254406,"marketCap":176551489},{"date":"2022-12-23","current":-0.662187,"twenty":-20.170872,"median":-1.761143,"eighty":-1.246835,"marketCap":185270081},{"date":"2022-12-30","current":-0.584283,"twenty":-19.910465,"median":-1.729267,"eighty":-1.233091,"marketCap":163473601},{"date":"2023-01-06","current":-0.646606,"twenty":-19.910465,"median":-1.709507,"eighty":-1.220425,"marketCap":180910785},{"date":"2023-01-13","current":-0.864739,"twenty":-19.727655,"median":-1.700287,"eighty":-1.204982,"marketCap":241940930},{"date":"2023-01-20","current":-0.705035,"twenty":-19.324279,"median":-1.696599,"eighty":-1.18418,"marketCap":197258145},{"date":"2023-01-27","current":-0.966014,"twenty":-19.073908,"median":-1.680001,"eighty":-1.168577,"marketCap":270276354},{"date":"2023-02-03","current":-0.817996,"twenty":-19.036154,"median":-1.663404,"eighty":-1.145789,"marketCap":228863042},{"date":"2023-02-10","current":-0.697244,"twenty":-18.849703,"median":-1.652339,"eighty":-1.126955,"marketCap":195078497},{"date":"2023-02-17","current":-0.759568,"twenty":-18.510377,"median":-1.599988,"eighty":-1.120876,"marketCap":212515681},{"date":"2023-02-24","current":-0.669978,"twenty":-18.137426,"median":-1.580986,"eighty":-1.092453,"marketCap":187449729},{"date":"2023-03-03","current":-0.681663,"twenty":-17.656234,"median":-1.570639,"eighty":-1.028927,"marketCap":190719201},{"date":"2023-03-10","current":-0.689454,"twenty":-15.84292,"median":-1.562021,"eighty":-1.00081,"marketCap":192898849},{"date":"2023-03-17","current":-0.588178,"twenty":-12.481002,"median":-1.538592,"eighty":-0.965462,"marketCap":164563425},{"date":"2023-03-24","current":-0.592742,"twenty":-10.968835,"median":-1.527779,"eighty":-0.894342,"marketCap":143038670},{"date":"2023-03-31","current":-0.54297,"twenty":-10.872382,"median":-1.517437,"eighty":-0.884215,"marketCap":131027790},{"date":"2023-04-06","current":-0.538445,"twenty":-10.810224,"median":-1.510673,"eighty":-0.88032,"marketCap":129935891},{"date":"2023-04-14","current":-0.534538,"twenty":-10.69448,"median":-1.497376,"eighty":-0.857727,"marketCap":128993146},{"date":"2023-04-21","current":-0.539068,"twenty":-10.424412,"median":-1.489775,"eighty":-0.829682,"marketCap":130086308},{"date":"2023-04-28","current":-0.511888,"twenty":-10.250797,"median":-1.484646,"eighty":-0.81488,"marketCap":123527335},{"date":"2023-05-05","current":-0.534538,"twenty":-10.004306,"median":-1.471564,"eighty":-0.788392,"marketCap":128993146},{"date":"2023-05-12","current":-0.888336,"twenty":-9.42023,"median":-1.465302,"eighty":-0.768137,"marketCap":156322203},{"date":"2023-05-19","current":-0.777692,"twenty":-7.308984,"median":-1.45367,"eighty":-0.771253,"marketCap":136852082},{"date":"2023-05-26","current":-0.914566,"twenty":-6.075459,"median":-1.441122,"eighty":-0.771297,"marketCap":160938049},{"date":"2023-06-02","current":-0.933231,"twenty":-5.771097,"median":-1.436569,"eighty":-0.771471,"marketCap":164222499},{"date":"2023-06-09","current":-0.839908,"twenty":-5.513889,"median":-1.428574,"eighty":-0.777692,"marketCap":147800249},{"date":"2023-06-16","current":-0.796357,"twenty":-5.358493,"median":-1.425167,"eighty":-0.783914,"marketCap":140136532},{"date":"2023-06-23","current":-0.659483,"twenty":-5.277043,"median":-1.40727,"eighty":-0.771253,"marketCap":116050565},{"date":"2023-06-30","current":-0.703034,"twenty":-5.076636,"median":-1.402434,"eighty":-0.766514,"marketCap":123714282},{"date":"2023-07-07","current":-0.696812,"twenty":-4.903021,"median":-1.400732,"eighty":-0.759568,"marketCap":122619465},{"date":"2023-07-14","current":-0.858572,"twenty":-4.803353,"median":-1.392762,"eighty":-0.759568,"marketCap":151084699},{"date":"2023-07-21","current":-0.902123,"twenty":-4.720832,"median":-1.38309,"eighty":-0.76184,"marketCap":158748415},{"date":"2023-07-28","current":-0.902123,"twenty":-4.548289,"median":-1.369067,"eighty":-0.766093,"marketCap":158748415},{"date":"2023-08-04","current":-0.920788,"twenty":-4.339308,"median":-1.356759,"eighty":-0.767358,"marketCap":162032865},{"date":"2023-08-11","current":-0.964339,"twenty":-4.226779,"median":-1.354805,"eighty":-0.768916,"marketCap":169696582},{"date":"2023-08-18","current":-1.071184,"twenty":-4.212847,"median":-1.341126,"eighty":-0.771253,"marketCap":187682117},{"date":"2023-08-25","current":-1.115033,"twenty":-4.206417,"median":-1.331904,"eighty":-0.77134,"marketCap":195365010},{"date":"2023-09-01","current":-1.165147,"twenty":-4.187126,"median":-1.325058,"eighty":-0.771471,"marketCap":204145460},{"date":"2023-09-08","current":-1.108769,"twenty":-4.137828,"median":-1.318774,"eighty":-0.772715,"marketCap":194267454},{"date":"2023-09-15","current":-1.102505,"twenty":-4.046734,"median":-1.300575,"eighty":-0.778936,"marketCap":193169898},{"date":"2023-09-22","current":-1.039863,"twenty":-3.993149,"median":-1.292152,"eighty":-0.783914,"marketCap":182194335},{"date":"2023-09-29","current":-1.108769,"twenty":-3.92456,"median":-1.28265,"eighty":-0.784498,"marketCap":194267454},{"date":"2023-10-06","current":-1.02107,"twenty":-3.890266,"median":-1.27286,"eighty":-0.788392,"marketCap":178901667},{"date":"2023-10-13","current":-1.033598,"twenty":-3.885979,"median":-1.257306,"eighty":-0.794625,"marketCap":181096779},{"date":"2023-10-20","current":-0.989749,"twenty":-3.864545,"median":-1.253862,"eighty":-0.794971,"marketCap":173413885},{"date":"2023-10-27","current":-1.039863,"twenty":-3.855972,"median":-1.250062,"eighty":-0.795664,"marketCap":182194335},{"date":"2023-11-03","current":-0.970956,"twenty":-3.824892,"median":-1.24107,"eighty":-0.80009,"marketCap":170121217},{"date":"2023-11-10","current":-0.876993,"twenty":-3.803458,"median":-1.233091,"eighty":-0.803649,"marketCap":153657873},{"date":"2023-11-17","current":-0.974107,"twenty":-3.770235,"median":-1.223778,"eighty":-0.807025,"marketCap":165172440},{"date":"2023-11-24","current":-0.967613,"twenty":-3.727368,"median":-1.213951,"eighty":-0.8088,"marketCap":164071290},{"date":"2023-12-01","current":-0.993589,"twenty":-3.668424,"median":-1.20606,"eighty":-0.8088,"marketCap":168475888},{"date":"2023-12-08","current":-1.097493,"twenty":-3.624484,"median":-1.192112,"eighty":-0.81092,"marketCap":186094282},{"date":"2023-12-15","current":-1.116976,"twenty":-3.600907,"median":-1.17787,"eighty":-0.815659,"marketCap":189397731},{"date":"2023-12-22","current":-2.435267,"twenty":-3.563398,"median":-1.186164,"eighty":-0.817996,"marketCap":412931100},{"date":"2023-12-29","current":-2.545665,"twenty":-3.531247,"median":-1.195838,"eighty":-0.817996,"marketCap":431650643},{"date":"2024-01-05","current":-2.435267,"twenty":-3.511956,"median":-1.203364,"eighty":-0.820333,"marketCap":412931100},{"date":"2024-01-12","current":-2.688534,"twenty":-3.495881,"median":-1.213437,"eighty":-0.826566,"marketCap":455875934},{"date":"2024-01-19","current":-2.883356,"twenty":-3.48945,"median":-1.221915,"eighty":-0.829682,"marketCap":488910422},{"date":"2024-01-26","current":-2.876862,"twenty":-3.47659,"median":-1.233091,"eighty":-0.83124,"marketCap":487809272},{"date":"2024-02-02","current":-3.117141,"twenty":-3.460515,"median":-1.235593,"eighty":-0.833621,"marketCap":528551808},{"date":"2024-02-09","current":-3.272998,"twenty":-3.448726,"median":-1.249027,"eighty":-0.836175,"marketCap":554979398},{"date":"2024-02-16","current":-2.88069,"twenty":-3.448726,"median":-1.254147,"eighty":-0.839908,"marketCap":488458412},{"date":"2024-02-23","current":-2.831627,"twenty":-3.444439,"median":-1.259169,"eighty":-0.842397,"marketCap":480139169},{"date":"2024-03-01","current":-2.754528,"twenty":-3.436937,"median":-1.274905,"eighty":-0.852491,"marketCap":467066072},{"date":"2024-03-08","current":-2.670421,"twenty":-3.41979,"median":-1.284551,"eighty":-0.853832,"marketCap":452804513},{"date":"2024-03-15","current":-2.558277,"twenty":-3.401571,"median":-1.29463,"eighty":-0.857273,"marketCap":433789100},{"date":"2024-03-22","current":-2.165774,"twenty":-3.391926,"median":-1.301003,"eighty":-0.858572,"marketCap":367235156},{"date":"2024-03-28","current":-2.393164,"twenty":-3.370492,"median":-1.318774,"eighty":-0.858572,"marketCap":475385316},{"date":"2024-04-05","current":-2.148639,"twenty":-3.311549,"median":-1.327504,"eighty":-0.860844,"marketCap":426812003},{"date":"2024-04-12","current":-1.833545,"twenty":-3.311549,"median":-1.333653,"eighty":-0.864739,"marketCap":364220857},{"date":"2024-04-19","current":-1.410419,"twenty":-3.279398,"median":-1.341342,"eighty":-0.864794,"marketCap":280169890},{"date":"2024-04-26","current":-1.242369,"twenty":-3.274039,"median":-1.341126,"eighty":-0.864794,"marketCap":246787946},{"date":"2024-05-03","current":-1.422423,"twenty":-3.272998,"median":-1.339441,"eighty":-0.864794,"marketCap":282554315},{"date":"2024-05-10","current":-1.452432,"twenty":-3.268681,"median":-1.354074,"eighty":-0.871015,"marketCap":288515376},{"date":"2024-05-17","current":-1.412314,"twenty":-3.26001,"median":-1.355782,"eighty":-0.876993,"marketCap":292092013},{"date":"2024-05-24","current":-1.158674,"twenty":-3.225813,"median":-1.354074,"eighty":-0.877237,"marketCap":239634672},{"date":"2024-05-31","current":-1.043383,"twenty":-3.211609,"median":-1.341126,"eighty":-0.879703,"marketCap":215790426},{"date":"2024-06-07","current":-1.009596,"twenty":-3.192472,"median":-1.333025,"eighty":-0.88032,"marketCap":208802627},{"date":"2024-06-14","current":-0.98075,"twenty":-3.181982,"median":-1.330053,"eighty":-0.88032,"marketCap":202836837},{"date":"2024-06-21","current":-0.755755,"twenty":-3.174189,"median":-1.321916,"eighty":-0.87847,"marketCap":156303680},{"date":"2024-06-28","current":-0.692294,"twenty":-3.170792,"median":-1.318774,"eighty":-0.877188,"marketCap":143178944},{"date":"2024-07-05","current":-0.634603,"twenty":-3.142038,"median":-1.315549,"eighty":-0.864794,"marketCap":131247365},{"date":"2024-07-12","current":-0.674987,"twenty":-3.119885,"median":-1.301003,"eighty":-0.859935,"marketCap":139599470},{"date":"2024-07-15","current":-0.686525,"twenty":-3.118513,"median":-1.300575,"eighty":-0.858572,"marketCap":141985786},{"date":"2024-08-02","current":-0.68941,"twenty":-3.117141,"median":-1.300147,"eighty":-0.858572,"marketCap":142582365},{"date":"2024-08-09","current":-0.605758,"twenty":-3.097659,"median":-1.294588,"eighty":-0.848061,"marketCap":125281576},{"date":"2024-08-16","current":-0.60941,"twenty":-3.065189,"median":-1.28637,"eighty":-0.833577,"marketCap":124220340},{"date":"2024-08-23","current":-0.514541,"twenty":-3.055914,"median":-1.279565,"eighty":-0.817996,"marketCap":104882577},{"date":"2024-08-30","current":-0.517764,"twenty":-3.054341,"median":-1.273965,"eighty":-0.8088,"marketCap":105539512},{"date":"2024-09-06","current":-0.498896,"twenty":-3.052629,"median":-1.268761,"eighty":-0.804006,"marketCap":101693459},{"date":"2024-09-13","current":-0.673867,"twenty":-3.052201,"median":-1.254795,"eighty":-0.793067,"marketCap":137359030},{"date":"2024-09-20","current":-0.714885,"twenty":-3.043957,"median":-1.250062,"eighty":-0.776448,"marketCap":145720014},{"date":"2024-09-27","current":-0.60941,"twenty":-3.030682,"median":-1.247269,"eighty":-0.770474,"marketCap":124220340},{"date":"2024-10-04","current":-0.562884,"twenty":-3.005449,"median":-1.242369,"eighty":-0.759568,"marketCap":114736595},{"date":"2024-10-11","current":-0.529894,"twenty":-2.97914,"median":-1.234118,"eighty":-0.750739,"marketCap":108011974},{"date":"2024-10-18","current":-0.61527,"twenty":-2.95253,"median":-1.22564,"eighty":-0.739313,"marketCap":125414766},{"date":"2024-10-25","current":-0.57935,"twenty":-2.944451,"median":-1.213951,"eighty":-0.734142,"marketCap":118092933},{"date":"2024-10-31","current":-0.533292,"twenty":-2.934797,"median":-1.206537,"eighty":-0.729185,"marketCap":108704742},{"date":"2024-11-08","current":-0.585971,"twenty":-2.925172,"median":-1.195838,"eighty":-0.709709,"marketCap":119442635},{"date":"2024-11-15","current":-0.419997,"twenty":-2.922744,"median":-1.180905,"eighty":-0.703113,"marketCap":94556475},{"date":"2024-11-22","current":-0.371808,"twenty":-2.92249,"median":-1.17407,"eighty":-0.697071,"marketCap":83707301},{"date":"2024-11-29","current":-0.37117,"twenty":-2.91193,"median":-1.166035,"eighty":-0.69059,"marketCap":83563762},{"date":"2024-12-06","current":-0.303269,"twenty":-2.891149,"median":-1.165147,"eighty":-0.68557,"marketCap":68276832},{"date":"2024-12-13","current":-0.308104,"twenty":-2.88229,"median":-1.162672,"eighty":-0.679326,"marketCap":69365338},{"date":"2024-12-20","current":-0.228302,"twenty":-2.879159,"median":-1.158778,"eighty":-0.673873,"marketCap":51399010},{"date":"2024-12-27","current":-0.281805,"twenty":-2.876862,"median":-1.150014,"eighty":-0.673867,"marketCap":63444344},{"date":"2025-01-03","current":-0.255027,"twenty":-2.876862,"median":-1.146355,"eighty":-0.669978,"marketCap":57415696},{"date":"2025-01-10","current":-0.245198,"twenty":-2.874317,"median":-1.138593,"eighty":-0.663197,"marketCap":55202800},{"date":"2025-01-17","current":-0.233403,"twenty":-2.868171,"median":-1.132275,"eighty":-0.656796,"marketCap":52547324},{"date":"2025-01-24","current":-0.222245,"twenty":-2.85831,"median":-1.128781,"eighty":-0.646866,"marketCap":50035387},{"date":"2025-01-31","current":-0.207209,"twenty":-2.840038,"median":-1.124676,"eighty":-0.643039,"marketCap":46650253},{"date":"2025-02-07","current":-1.051985,"twenty":-2.823791,"median":-1.121298,"eighty":-0.64111,"marketCap":236839749},{"date":"2025-02-14","current":-0.733202,"twenty":-2.818476,"median":-1.120876,"eighty":-0.643039,"marketCap":165070128},{"date":"2025-02-21","current":-0.64288,"twenty":-2.812485,"median":-1.118477,"eighty":-0.643031,"marketCap":144735402},{"date":"2025-02-28","current":-0.658819,"twenty":-2.803591,"median":-1.116976,"eighty":-0.644411,"marketCap":148323883},{"date":"2025-03-07","current":-0.547245,"twenty":-2.801008,"median":-1.110663,"eighty":-0.636245,"marketCap":123204516},{"date":"2025-03-14","current":-0.431473,"twenty":-2.796913,"median":-1.108769,"eighty":-0.631096,"marketCap":97140182},{"date":"2025-03-21","current":-0.521427,"twenty":-2.792516,"median":-1.102505,"eighty":-0.62713,"marketCap":88603523},{"date":"2025-03-28","current":-0.43064,"twenty":-2.784875,"median":-1.097493,"eighty":-0.619015,"marketCap":73176481},{"date":"2025-04-04","current":-0.388282,"twenty":-2.77135,"median":-1.096241,"eighty":-0.613037,"marketCap":65978794},{"date":"2025-04-11","current":-0.356513,"twenty":-2.754107,"median":-1.09048,"eighty":-0.611536,"marketCap":60580529},{"date":"2025-04-17","current":-0.332722,"twenty":-2.752176,"median":-1.083864,"eighty":-0.609696,"marketCap":56537829},{"date":"2025-04-25","current":-0.471868,"twenty":-2.738793,"median":-1.080862,"eighty":-0.606488,"marketCap":80182229},{"date":"2025-05-02","current":-0.428663,"twenty":-2.703896,"median":-1.071184,"eighty":-0.598126,"marketCap":72840589},{"date":"2025-05-09","current":-0.416521,"twenty":-2.69425,"median":-1.060024,"eighty":-0.594913,"marketCap":70777252},{"date":"2025-05-16","current":-0.591746,"twenty":-2.689677,"median":-1.057662,"eighty":-0.591763,"marketCap":84452857},{"date":"2025-05-23","current":-0.639237,"twenty":-2.687748,"median":-1.049056,"eighty":-0.592013,"marketCap":91230678},{"date":"2025-05-30","current":-0.712617,"twenty":-2.684605,"median":-1.046127,"eighty":-0.592742,"marketCap":101703313},{"date":"2025-06-06","current":-0.777592,"twenty":-2.679246,"median":-1.043383,"eighty":-0.594219,"marketCap":110976332},{"date":"2025-06-13","current":-0.711777,"twenty":-2.677429,"median":-1.039863,"eighty":-0.597691,"marketCap":101583351},{"date":"2025-06-20","current":-0.629571,"twenty":-2.675923,"median":-1.039153,"eighty":-0.597691,"marketCap":89851122},{"date":"2025-06-27","current":-0.671514,"twenty":-2.67422,"median":-1.033598,"eighty":-0.596997,"marketCap":95837198},{"date":"2025-07-03","current":-0.617887,"twenty":-2.671808,"median":-1.033598,"eighty":-0.597691,"marketCap":88183658},{"date":"2025-07-11","current":-0.626545,"twenty":-2.667044,"median":-1.033598,"eighty":-0.597691,"marketCap":89419261},{"date":"2025-07-18","current":-0.606624,"twenty":-2.663819,"median":-1.033486,"eighty":-0.596302,"marketCap":86576174},{"date":"2025-07-25","current":-0.680845,"twenty":-2.662803,"median":-1.027334,"eighty":-0.597691,"marketCap":97168770},{"date":"2025-08-01","current":-0.583341,"twenty":-2.658865,"median":-1.025887,"eighty":-0.597691,"marketCap":83253242},{"date":"2025-08-08","current":-0.633438,"twenty":-2.628925,"median":-1.018217,"eighty":-0.597691,"marketCap":90402944},{"date":"2025-08-15","current":-0.671851,"twenty":-2.608646,"median":-1.01456,"eighty":-0.597691,"marketCap":95885182},{"date":"2025-08-22","current":-0.57589,"twenty":-2.594724,"median":-1.009192,"eighty":-0.597691,"marketCap":63423389},{"date":"2025-08-29","current":-1.752501,"twenty":-2.586313,"median":-1.009596,"eighty":-0.598995,"marketCap":193004672},{"date":"2025-09-05","current":-1.765777,"twenty":-2.577902,"median":-1.01456,"eighty":-0.600315,"marketCap":194466829},{"date":"2025-09-12","current":-2.17735,"twenty":-2.562482,"median":-1.018217,"eighty":-0.601664,"marketCap":239793684},{"date":"2025-09-19","current":-2.212754,"twenty":-2.555269,"median":-1.025887,"eighty":-0.603107,"marketCap":243692768},{"date":"2025-09-26","current":-2.018031,"twenty":-2.548721,"median":-1.027334,"eighty":-0.604535,"marketCap":222247805},{"date":"2025-10-03","current":-2.159648,"twenty":-2.542299,"median":-1.033486,"eighty":-0.605723,"marketCap":237844142},{"date":"2025-10-10","current":-3.345683,"twenty":-2.555269,"median":-1.033598,"eighty":-0.605758,"marketCap":368463466},{"date":"2025-10-17","current":-3.407002,"twenty":-2.598929,"median":-1.033598,"eighty":-0.605936,"marketCap":375216537},{"date":"2025-10-24","current":-3.776905,"twenty":-2.662926,"median":-1.033598,"eighty":-0.606372,"marketCap":415954333},{"date":"2025-10-31","current":-3.640625,"twenty":-2.674883,"median":-1.039863,"eighty":-0.607081,"marketCap":400945671},{"date":"2025-11-07","current":-5.515862,"twenty":-2.686962,"median":-1.039863,"eighty":-0.608117,"marketCap":330190553},{"date":"2025-11-14","current":-6.892977,"twenty":-2.717777,"median":-1.044211,"eighty":-0.608949,"marketCap":412627416},{"date":"2025-11-21","current":-9.34641,"twenty":-2.77135,"median":-1.046127,"eighty":-0.60941,"marketCap":559494801},{"date":"2025-11-28","current":-9.46324,"twenty":-2.797023,"median":-1.052188,"eighty":-0.60941,"marketCap":566488486},{"date":"2025-12-05","current":-8.645429,"twenty":-2.818537,"median":-1.058529,"eighty":-0.60941,"marketCap":517532691},{"date":"2025-12-12","current":-9.268523,"twenty":-2.872304,"median":-1.063219,"eighty":-0.60966,"marketCap":554832344},{"date":"2025-12-19","current":-8.918033,"twenty":-2.882823,"median":-1.071185,"eighty":-0.610693,"marketCap":533851289},{"date":"2025-12-26","current":-10.943088,"twenty":-2.903133,"median":-1.083712,"eighty":-0.610827,"marketCap":655075163},{"date":"2026-01-02","current":-9.619014,"twenty":-2.923958,"median":-1.083864,"eighty":-0.610838,"marketCap":575813399},{"date":"2026-01-09","current":-11.619697,"twenty":-2.97914,"median":-1.092947,"eighty":-0.610897,"marketCap":695578313},{"date":"2026-01-16","current":-11.493909,"twenty":-3.052201,"median":-1.096241,"eighty":-0.611404,"marketCap":688048360},{"date":"2026-01-23","current":-10.410466,"twenty":-3.059624,"median":-1.097493,"eighty":-0.611527,"marketCap":623191342},{"date":"2026-01-30","current":-8.714644,"twenty":-3.119885,"median":-1.102505,"eighty":-0.61154,"marketCap":521676011},{"date":"2026-02-06","current":-8.055157,"twenty":-3.175062,"median":-1.108769,"eighty":-0.611549,"marketCap":482197826},{"date":"2026-02-13","current":-7.207246,"twenty":-3.239492,"median":-1.110663,"eighty":-0.611549,"marketCap":431440160},{"date":"2026-02-20","current":-7.584095,"twenty":-3.273623,"median":-1.116004,"eighty":-0.611549,"marketCap":453999123},{"date":"2026-02-27","current":-8.008051,"twenty":-3.321408,"median":-1.117077,"eighty":-0.611697,"marketCap":479377956},{"date":"2026-03-06","current":-9.347815,"twenty":-3.393384,"median":-1.120876,"eighty":-0.61326,"marketCap":490657437},{"date":"2026-03-13","current":-9.690993,"twenty":-3.417247,"median":-1.121298,"eighty":-0.61527,"marketCap":508670512},{"date":"2026-03-20","current":-7.806633,"twenty":-3.448726,"median":-1.124676,"eighty":-0.615376,"marketCap":409762357},{"date":"2026-03-27","current":-8.129666,"twenty":-3.492431,"median":-1.128781,"eighty":-0.615752,"marketCap":426718040}],"updateTime":1774747230103},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVVD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606015734","title":"Institutional investors in Invivyd, Inc. (NASDAQ:IVVD) see US$113m decrease in market cap last week, although long-term gains have benefitted them.","url":"https://stock-news.laohu8.com/highlight/detail?id=2606015734","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606015734?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:56","pubTimestamp":1769529386,"startTime":"0","endTime":"0","summary":"Key Insights Institutions' substantial holdings in Invivyd implies that they have significant influence over the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/institutional-investors-in-invivyd-inc-nasdaqivvd-see-us113m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/institutional-investors-in-invivyd-inc-nasdaqivvd-see-us113m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QLD","NQmain","QID","USAW.SI","TQQQ",".IXIC","QQQJ","JEPQ","BK4539","NVIW.SI","GPIQ","QYLD","QQQY","MNQmain","QQQM","IVVD","USJW.SI","PSQ","QYLG","QQQE","SQQQ","TSYW.SI","BK4139"],"gpt_icon":1},{"id":"2605495778","title":"BUZZ-Invivyd rises after team-up with Olympic skier Lindsey Vonn","url":"https://stock-news.laohu8.com/highlight/detail?id=2605495778","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605495778?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:22","pubTimestamp":1769084547,"startTime":"0","endTime":"0","summary":"BUZZ-Invivyd rises after team-up with Olympic skier Lindsey Vonn** Shares of drugmaker Invivyd IVVD.O rise 2.26% to $2.26 premarket** Co says it has partnered with Olympic gold medalist Lindsey Vonn to launch a national campaign educating Americans on antibodies, which are proteins the body uses to fight infections** The spring 2026 campaign will feature Vonn as spokesperson after her return to competitive skiing and qualification for the 2026 Winter Games - IVVD** IVVD rose ~457% in 2025","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL4N3YN0X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2605495241","title":"Invivyd announces partnership with ski champion Lindsey Vonn","url":"https://stock-news.laohu8.com/highlight/detail?id=2605495241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605495241?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:16","pubTimestamp":1769084213,"startTime":"0","endTime":"0","summary":"Invivyd (IVVD) announced a partnership with ski champion Lindsey Vonn to elevate public understanding of antibodies, one of the most important part...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invivyd-announces-partnership-with-ski-champion-lindsey-vonn-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invivyd-announces-partnership-with-ski-champion-lindsey-vonn-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2605495837","title":"Invivyd Partners with Lindsey Vonn to Promote Antibody Education","url":"https://stock-news.laohu8.com/highlight/detail?id=2605495837","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605495837?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:02","pubTimestamp":1769083350,"startTime":"0","endTime":"0","summary":"Invivyd Inc. has announced a partnership with world champion skier Lindsey Vonn to launch an educational campaign focused on antibodies and disease prevention. The collaboration aims to increase public understanding of the role antibodies play in maintaining health and preventing infectious diseases. Lindsey Vonn will serve as the spokesperson for the initiative, which is set to begin in spring 2026 following her competitive comeback season. The campaign will utilize a national multimedia approach to make antibody science accessible and relatable to a broad audience.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invivyd Inc. published the original content used to generate this news brief via GlobeNewswire  on January 22, 2026, and is ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL1TJ3wD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014005.SGD","SG9999014039.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","BK4539","LU0314104364.USD","IVVD","BK4585","IE00BKPKM429.USD","SG9999014013.SGD","BK4139","LU2095319765.USD","BK4112"],"gpt_icon":0},{"id":"2605449327","title":"Invivyd Announces Partnership With World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2605449327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605449327?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:01","pubTimestamp":1769083260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUA3SZ8FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2604113568","title":"Invivyd to Launch Mid-Stage Trial for Investigational Antibody on Long COVID","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113568","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113568?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:58","pubTimestamp":1768913900,"startTime":"0","endTime":"0","summary":"Invivyd  said Tuesday that it plans to launch a mid-stage clinical trial, along with the SPEAR Study Group, that assesses the safety, translational biology, and exploratory clinical efficacy of investigational antibody VYD2311 in individuals with Long COVID or COVID vaccine injury.The trial will evaluate multiple high doses of the antibody across many months of therapy, the company said.The mid-stage trial is expected to begin by mid-2026, with further details to be announced in the coming months, Invivyd said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","IVVD","SSI"],"gpt_icon":0},{"id":"2604190466","title":"Invivyd and Spear Study Group Announce Plan for Phase 2 Study of Vyd2311 for Treatment of Long Covid and Covid Vaccine-Injured Individuals to Commence Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190466?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:12","pubTimestamp":1768911132,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0FE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"2604190006","title":"Invivyd, SPEAR Study Group plan to initiate Phase 2 trial of VYD2311","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190006","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190006?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:11","pubTimestamp":1768911101,"startTime":"0","endTime":"0","summary":"Invivyd (IVVD) and the SPEAR Study Group announced the plan to initiate a Phase 2 clinical trial evaluating monoclonal antibody VYD2311 in individu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invivyd-spear-study-group-plan-to-initiate-phase-2-trial-of-vyd2311-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invivyd-spear-study-group-plan-to-initiate-phase-2-trial-of-vyd2311-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"2601366269","title":"Invivyd Reports Preliminary Q4 Revenue and Launches Phase 3 DECLARATION Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366269","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366269?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:02","pubTimestamp":1767873773,"startTime":"0","endTime":"0","summary":"Invivyd Inc. announced preliminary fourth quarter 2025 results, reporting PEMGARDA  net product revenue of $17.2 million, reflecting a 25% increase year-over-year and a 31% increase quarter-over-quarter. The company ended 2025 with cash and cash equivalents of $226.7 million, following the raising of over $200 million through financing transactions in the second half of the year. Invivyd also reported 281,987,033 shares of common stock outstanding as of December 31, 2025, excluding 27,342,442 pre-funded warrants. The company highlighted the initiation of the DECLARATION Phase 3 clinical trial for its vaccine-alternative antibody VYD2311 for COVID-19 prevention, with top-line data expected in mid-2026 and Fast Track designation granted by the FDA in December 2025. Additional pipeline updates included the nomination of RSV antibody VBY329 for preclinical development and plans for selecting a preclinical measles monoclonal antibody candidate in the first half of 2026. Further updates are ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLbwt9Ks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","NDAQ","IE00BKPKM429.USD","SG9999014005.SGD","BK4588","BK4139","SG9999014013.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4539","IVVD","IE00B64PRP62.GBP","BK4585","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","LU0314104364.USD","BK4112"],"gpt_icon":0},{"id":"2601366211","title":"Invivyd Inc - Prelim Q4 2025 Pemgarda Revenue of $17.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366211?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:01","pubTimestamp":1767873660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUABHKGSB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"2601366232","title":"Press Release: Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366232","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366232?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:01","pubTimestamp":1767873660,"startTime":"0","endTime":"0","summary":"-- Preliminary Q4 2025 PEMGARDA  net product revenue of $17.2. million, representing 25% growth year-over-year and 31% growth. -- Preliminary ending 2025 cash and cash equivalents of $226.7 million after. raising over $200 million from financing transactions in 2H 2025. vaccine-alternative antibody VYD2311 to prevent COVID, with top-line data. expected mid-2026; Fast Track designation for VYD2311 granted by FDA in. \"We are pleased by strong top-line revenue growth of PEMGARDA , which we believe is attributable to our commercial execution and the fundamental appeal of monoclonal antibody prophylaxis even in the face of declining COVID vaccination trends. We are actively preparing for the potential commercial launch of VYD2311, an accessible vaccine-alternative to prevent COVID, which, if approved, could represent a step-change from PEMGARDA, a specialty medicine for the immunocompromised,\" noted Bill Duke, Chief Financial Officer of Invivyd. \"With a strong balance sheet bolstered by our","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4139","BK4539","IVVD","R","BK4232"],"gpt_icon":0},{"id":"2593479252","title":"Invivyd Price Target Maintained With a $10.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2593479252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593479252?lang=en_us&edition=fundamental","pubTime":"2025-12-24 19:11","pubTimestamp":1766574660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVVD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 24, 2025 06:11 ET (11:11 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2593411172","title":"BUZZ-U.S. STOCKS ON THE MOVE-Invivyd, US natgas companies, New Era Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2593411172","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593411172?lang=en_us&edition=fundamental","pubTime":"2025-12-24 00:20","pubTimestamp":1766506815,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Invivyd, US natgas companies, New Era EnergyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL6N3XT0OD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","BK4501","LU0006061336.USD","LU1169590202.USD","SGXZ51526630.SGD","BK4161","IE00B2PGVK34.USD","SG9999017495.SGD","LU1674673428.USD","LU2602419157.SGD","LU0823421416.USD","LU1923622291.USD","LU2168564495.EUR","BK4210","LU0061475181.USD","LU0128525929.USD","LU1992135472.HKD","BK4551","BK4588","LU1861558580.USD","LU0823434583.USD","BK4007","LU1023059493.AUD","IE00BMPRXN33.USD","LU0097036916.USD","LU1323610961.USD","LU0630314457.HKD","SG9999018857.SGD","LU1868836757.USD","LU0353189680.USD","LU0965509101.SGD","LU2023251221.USD","IE00B19Z9P08.USD","LU1037948897.HKD","LU1778281490.HKD","LU1983299246.USD","LU1127390331.HKD","IE0002141913.USD","LU0719512351.SGD","BK4527","IE00BKVL7J92.USD","LU1267930730.SGD","LU2250418816.HKD","LU0162691827.USD","LU2931357623.SGD","BK4583","LU0708995401.HKD","LU2361044949.HKD","LU0496367417.USD","SG9999014906.USD","LU2462611646.USD","LU1989764664.SGD","LU0820561818.USD","LU2063271972.USD","IE00B7SZLL34.SGD","LU0314106906.USD","BK4512","IE00B3T34201.USD","LU0289739699.SGD","LU1989764748.USD","LU1923622614.USD","LU1585245621.USD","BK4532","LU2028103732.USD","SG9999014880.SGD","LU0354030438.USD","LU0498741114.HKD","LU0266013472.USD","BK4096","BK4568","SG9999001176.USD","LU0943347566.SGD","IE0004445015.USD","LU0642271901.SGD","SG9999001176.SGD","LU0724618433.USD","IE00BJT1NW94.SGD","LU1623119135.USD","LU2237443465.HKD","LU2125909247.SGD","LU0345780281.USD","LU0345780950.USD","LU0823434740.USD","LU1316542783.SGD","LU0124384867.USD","LU0792757196.USD","LU0109391861.USD","LU1223083913.SGD","LU2552382215.SGD","LU1221951046.USD","LU0323239441.USD","LU2286300806.USD","IE00BMPRXR70.SGD","LU0122379950.USD","LU0265550359.USD","LU0256863811.USD","BK4578","LU0672654240.SGD","LU2461242641.AUD","LU1366333091.USD","LU1430597077.USD","UNG","LU2237443895.HKD","LU1917777945.USD","LU2361045086.USD","LU1223082196.USD","SG9999014898.SGD","BK4127","LU0345780521.USD","LU0417517546.SGD","LU0266512473.USD","LU1839511570.USD","LU1951200564.SGD","LU1934455277.USD","LU1988902786.USD","BK4213","BK4214","LU2111349929.HKD","LU0029864427.USD","BK4554","LU0203201768.USD","LU2112291526.USD","LU2471134796.USD","LU2272731865.HKD","IE00BQXX3C00.GBP","IE00BKDWB100.SGD","LU2048586759.USD","LU0787776722.HKD","LU0320765992.SGD","LU1712237335.SGD","IE00BK4W5L77.USD","LU0354030511.USD","LU2322448791.USD","LU0786609619.USD","LU0058720904.USD","LU1223082519.USD","LU0456854461.SGD","LU1430594728.SGD","LU0788108826.HKD","LU1196500208.SGD","LU0323240290.USD","IE00BQXX3F31.USD","LU1852331112.SGD","BK4141","LU1868837136.USD","LU2089985449.USD","LU1232071149.USD","BK4581","IE00BFTCPJ56.SGD","IE00BGHQF417.EUR","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0300736062.USD","LU0006306889.USD","LU2237443549.SGD","LU2237443622.USD","IE00B1XK9C88.USD","BK4516","LU0274383776.USD","IE00BLDYK493.USD","LU0432979614.USD","IE00BWXC8680.SGD","LU0385154629.USD","IE00B64QTZ34.USD","IE00BKPKM429.USD","LU2491050071.SGD","LU2023250504.SGD","LU0345781412.USD","LU1116320901.HKD","LU1804176565.USD","IE00BZ1G4Q59.USD","LU0106261372.USD","LU0861579265.USD","LU2322448957.HKD","LU1366192091.USD","LU2108987350.USD","SG9999002521.SGD","LU2265009873.SGD","LU1989772840.SGD","LU1720051017.SGD","LU1023059063.AUD","LU2357125470.USD","LU1571399168.USD","IE00BN29S564.USD","BK4548","LU1061106388.HKD","LU2264538146.SGD","IE00B19Z3581.USD","LU0330918003.SGD","LU1548497426.USD","LU1868836591.USD","LU0471298694.HKD","LU1506573853.SGD","LU2168564149.EUR","LU2125909593.SGD","LU1868836914.USD","LU0082616367.USD","BK4534","LU2168564222.USD","LU2237443382.USD","LU2360106947.USD","LU1934455863.HKD","LU1699723380.USD","LU0081259029.USD","LU2211814178.USD","LU1989771016.USD","LU1267930813.SGD","LU0203202063.USD","LU0072461881.USD","LU0055631609.USD","LU1064131342.USD","LU2089283258.USD","LU0158827781.USD","LU1551013342.USD","BK4575","LU2272731600.USD","IE00BQXX3D17.EUR","LU0889565916.HKD","BK4613","BK4519","LU1267930573.SGD","LU2458330243.SGD","LU2746668461.USD","LU2746668974.SGD","LU2552382058.USD","SGXZ31699556.SGD","BK4179","LU0882574139.USD","BK4212","LU2237443978.SGD","LU0310800379.SGD","BK4585","SG9999018865.SGD","LU2506951792.HKD","IE00BJLML261.HKD","IE00BJJMRX11.SGD","LU0266512127.USD","IE00B775H168.HKD","LU2417539215.USD","BK4605","SG9999014914.USD","LU0345770308.USD","LU0882574055.USD","LU0823421333.USD","BK4570","IE00B4JS1V06.HKD","SG9999015952.SGD","LU2294711713.HKD","LU0109392836.USD","LU0683600562.USD","LU2462157665.USD","LU0345770993.USD","LU2473716301.USD","LU2023250843.SGD","LU1221951129.SGD","LU1291159041.SGD","IE0004445239.USD","IE0005OL40V9.USD","LU0203345920.USD","BK4599","IE00B19Z3B42.SGD","LU0234570918.USD","SG9999015945.SGD","LU0053666078.USD","SG9999015978.USD","SG9999013999.USD","LU0820561909.HKD","LU1883866441.USD","LU0889566641.SGD","LU2360106780.USD","LU0238689110.USD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU0505663152.USD","LU2089984988.USD","BK4547","LU0612318385.USD","LU2271345857.HKD","IE00BFSS8Q28.SGD","LU2361044865.SGD","BK4097","LU0965508806.USD","LU0823414478.USD","LU2498475776.HKD","IE00B3CCJ633.GBP","LU2750360997.AUD","NUAI","LU0109394709.USD","LU1974910355.USD","BK4579","LU0114720955.EUR","LU0096364046.USD","IE00BK4W5M84.HKD","LU1989772923.USD","LU1978683503.SGD","BK4550","GB00BDT5M118.USD","LU0466842654.USD","LU2458330169.SGD","IE00B2B36J28.USD","LU0965509010.AUD","LU0724618789.USD","LU0265550946.USD","LU2211815571.USD","LU1934455194.USD","LU0256863902.USD","LU2750360641.GBP","LU2125909916.SGD","LU1868837300.USD","BK4528","LU0154245673.USD","LU2106854487.HKD","BK4533","BK4539","BK4015","BK4607","IE00BJJMRY28.SGD","LU2471134879.HKD","LU0158827948.USD","LU1169589451.USD","IVVD","LU1551013425.SGD","LU1280957306.USD","LU0312595415.SGD","LU0300736492.USD","BK4566","LU2433249047.HKD","BK4232","LU1037948541.HKD","LU1035775433.USD","LU0654597011.USD","LU1066053197.SGD","LU2491050154.USD","BK4608","LU2468319806.SGD","LU0965509283.SGD","SG9999001143.SGD","IE00B1BXHZ80.USD","LU0640476718.USD","LU0011850046.USD","LU2471134952.CNY","LU1674673691.USD","SGXZ99366536.SGD","LU0498741890.SGD","LU2168564065.EUR","SGXZ81514606.USD","LU0788109121.HKD","LU0154245756.USD","LU2089284900.SGD","LU0198837287.USD","LU0316494557.USD","LU0823416689.USD","LU1093756168.USD","LU0612318971.USD","LU1057294990.SGD","IE00B894F039.SGD","LU2381873111.SGD","LU2125909759.SGD","LU2272731782.SGD","LU1983299162.USD","LU1803068979.SGD","LU2543165471.USD","LU1153585028.USD","IE0009355771.USD","LU2471134523.USD","LU0889565833.HKD","LU1861559042.SGD","LU0203347892.USD","BK4123","LU0456855351.SGD","IE00B7KXQ091.USD","LU0079474960.USD","LU0157215616.USD","LU1066051498.USD","LU2456880835.USD","LU2324357040.USD","LU0094547139.USD","BK4020","LU1951198990.SGD","LU1814569148.SGD","LU0353189763.USD","LU2168563687.JPY","BK4503","LU2463526074.USD","LU2552382132.HKD","LU0471298777.SGD","BK4187","LU1923623000.USD","LU1992135399.USD","LU0689472784.USD","LU0056508442.USD","LU1093756325.SGD","LU2087621335.USD","LU2298322129.HKD","LU0234572021.USD","IE00B19Z9Z06.USD","LU1069344957.HKD","LU0278409577.USD","IE0002270589.USD","SG9999015986.USD","LU2357305700.SGD","LU0320765059.SGD","LU0708994859.HKD","LU0368265764.SGD","IE00BFSS7M15.SGD","LU0075056555.USD","BK4553","BK4139","LU1116320737.USD","LU0127658192.USD","IE00BZ9MQY76.HKD","LU2249611893.SGD","LU0348723411.USD","LU0823414551.USD","LU1032955483.USD","LU2491049909.HKD","LU0323591593.USD","LU1720051108.HKD","LU2237438978.USD","BK4017","BK4596","LU2087625088.SGD","BK4204","BK4543"],"gpt_icon":0},{"id":"2593166484","title":"Invivyd Shares Gain 3.8% After Co Starts Late-Stage Trial for Covid Prevention Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2593166484","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593166484?lang=en_us&edition=fundamental","pubTime":"2025-12-23 22:48","pubTimestamp":1766501283,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4N3XT0S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2593973944","title":"Invivyd Shares up 2% Premarket After Co Starts Late-Stage Trial for Covid Prevention Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2593973944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593973944?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:14","pubTimestamp":1766492073,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4N3XT0MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2593497365","title":"BUZZ-Invivyd rises as drugmaker starts late-stage trial for COVID prevention antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2593497365","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593497365?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:12","pubTimestamp":1766491962,"startTime":"0","endTime":"0","summary":"BUZZ-Invivyd rises as drugmaker starts late-stage trial for COVID prevention antibody** Shares of drugmaker Invivyd IVVD.O  rise 1.4% to $2.92 premarket** Co says it has started late-stage clinical trial to test its experimental COVID-19 antibody, VYD2311, as a preventive treatment for the disease** Study will enroll 1,770 adults and teens; compare single vs monthly shots to placebo, says co** IVVD says the goal is to offer vaccine alternative for high-risk people seeking protection** Top-line results expected by mid-2026 - IVVD** Up to last close, stock up ~133% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4N3XT0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"2593492009","title":"Invivyd Inc - FDA Grants Fast Track Designation for Invivyd's Vyd2311","url":"https://stock-news.laohu8.com/highlight/detail?id=2593492009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593492009?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:09","pubTimestamp":1766491763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT09M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","IVVD"],"gpt_icon":0},{"id":"2593018492","title":"FDA Grants Fast Track Designation to Invivyd's COVID Prevention Antibody VYD2311","url":"https://stock-news.laohu8.com/highlight/detail?id=2593018492","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593018492?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:05","pubTimestamp":1766491514,"startTime":"0","endTime":"0","summary":"Invivyd Inc. announced that the U.S. Food and Drug Administration  has granted Fast Track designation for its investigational monoclonal antibody candidate, VYD2311, intended as a vaccine-alternative for the prevention of COVID-19 in individuals with underlying risk factors for severe disease. The Fast Track designation is designed to expedite the development and review of drugs addressing serious or life-threatening conditions and allows for priority review and rolling Biologics License Application  submission if the relevant criteria are met. Additionally, in March 2024, Invivyd received emergency use authorization  from the FDA for a monoclonal antibody in its pipeline. No other organizations were specified as recipients of these regulatory actions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL63s3DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4588","IE00BKPKM429.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","IVVD","BK4139","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210150020.SGD","BK4539","LU2095319765.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","SG9999014005.SGD","BK4112","LU2210149790.SGD"],"gpt_icon":0},{"id":"2593492767","title":"Invivyd Launches Phase 3 Trial of VYD2311 Antibody for COVID Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2593492767","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593492767?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:01","pubTimestamp":1766491282,"startTime":"0","endTime":"0","summary":"Invivyd Inc. has announced the initiation of the DECLARATION clinical trial, a Phase 3 randomized, triple-blind, placebo-controlled study evaluating VYD2311, an investigational monoclonal antibody designed for the prevention of COVID-19. The DECLARATION trial will assess the efficacy and safety of VYD2311 in preventing symptomatic COVID-19 in adults and adolescents, with participants receiving either a single intramuscular dose or monthly doses, compared to placebo. The primary endpoint is reduction in PCR-confirmed symptomatic COVID incidence versus placebo at three months. The company expects to enroll approximately 1,770 participants across all study arms. Top-line results from the trial are anticipated in mid-2026. No results have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL1WhdR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","NDAQ","LU2095319765.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","IVVD","BK4588","BK4139","SG9999014039.USD","LU2210149790.SGD","BK4585","BK4539","LU2210150020.SGD","SG9999014013.SGD","BK4112","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2593922764","title":"Invivyd Inc - Top-Line Data Expected Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2593922764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593922764?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:01","pubTimestamp":1766491260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA2ZVNW8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":92,"code":"91000000","status":"200"}]}}